Type 1 diabetes patients on long-term, intensive therapy are more likely to achieve near-normal levels of blood glucose, as well as a significantly lower risk of developing heart disease, stroke, kidney problems and severe eye disease
Sean A. Newsom, Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the effect of an exercise session on insulin sensitivity and fatty acid uptake in a group of 11 sedentary obese adults.
University of Cambridge scientists have found a new immunological treatment that slows damage to the pancreas, preserving its ability to produce insulin without the use of diabetes medications.
The American Diabetes Association wants pharmaceutical companies to make available all patient-level data on their incretin products for an independent review “that could help settle the question of whether such therapies contribute to the development of pancreatic cancer” the organization said.
A new study by Queen’s University researchers has determined that adults who accumulated 150 minutes of exercise on a few days of the week were not any less healthy than adults who exercised more frequently throughout the week.
German scientists have found a way to predict a person’s risk of developing type 1 diabetes, their study has been published in the Journal of the American Medical Association.
University Hospitals Case Medical Center clinical researchers have launched an innovative clinical trial, unique in its design, which will evaluate the ability of a patient’s own stem cells to prevent leg amputations in end stage peripheral arterial disease (PAD).
Men who lose sleep during the work week may be able to lower their risk of developing Type 2 diabetes by getting more hours of sleep, according to Los Angeles Biomedical Research Institute
A special type of in vitro fertilization, or IVF, may increase the risk for insulin resistance among children conceived in this way, according to a new study from Greece.
Boston Children’s Hospital could be on the verge of curing type 1 diabetes. Seriously. This huge news, which was announced today on their blog, could affect the 215,000 people in the U.S. younger than 20 who have diabetes (type 1 or type 2).
The use of glyburide to treat gestational diabetes has become more frequent. Tempe A et al. conducted a prospective comparative study assessing the efficacy of glyburide to insulin in the treatment of gestational diabetes.
A recent study by Dr. Zhen Gu, is part of a growing area of research that seeks to eliminate this balancing act by developing a glucose responsive insulin (GRI). Dr. Gu’s study specifically tested a nanoparticle-based GRI that is injected into the body and releases insulin in response to blood-glucose fluctuations.
A study of older adults with diabetes mellitus (DM) suggests a bidirectional association between hypoglycemic (low blood glucose) events and dementia, according to a report published Online First by JAMA Internal Medicine, a JAMA Network publication.
Scientists have found a way to make insulin-producing cells multiply in the laboratory. This may allow clinicians to treat more patients who have type 1 diabetes with transplants of the cells
A major ingredient in those green coffee bean dietary supplements — often touted as “miracle” weight-loss products — doesn’t prevent weight gain in obese laboratory mice fed a high-fat diet when given at higher doses.
The TEDDY study, following nearly 9,000 at-risk children from birth to age 15, is enabling scientists to parse which genetic mutations correlate with progression or lack of progression to type 1 diabetes.
A few cups of hot cocoa may not only fight off the chill of a winter’s day, but they could also help obese people better control inflammation-related diseases, such as diabetes, according to Penn State researchers.
A study, out today, shows that moderately-paced walks after meals work as well at regulating overall blood sugar in adults with pre-diabetes as a 45-minute walk once a day.
Levels of estrone are associated with increased risk of incident type 2 diabetes in a cohort of community-dwelling men, according to a study published online May 20 in Diabetes Care.
New forms of diabetes drugs, known as GLP-1-based drugs, and promoted as “the new darlings of diabetes treatment” make the pharmaceutical industry billions. But are they associated with an increased risk of cancer and do we know everything we should about these new treatments?